Dhampur Bio Organics Ltd. announced reaffirmations and revisions to ratings across multiple instruments and agencies, including CARE Ratings Ltd., CARE Ratings Limited (CareEdge Ratings), and an assignment by CARE Ratings Limited. CARE Ratings reaffirmed the long-term bank facilities at CARE BBB+ with an outlook revised from Stable to Positive, alongside reaffirming the short-term bank facilities at CARE A2; the Long-term bank facilities were reduced from 1,019.45 to 987.05, and the Short-term bank facilities were reduced from 115.00 to 75.00. Additionally, CARE Ratings assigned a CARE A+ rating with a stable outlook to bank loan facilities totaling Rs. 200 crore, while also withdrawing ratings for Commercial Paper (Carved out) previously rated CARE A2+, CARE A1, and CARE A2, and noting support for DBOL’s profitability; various fund-based and non-fund-based facilities, including Long Term Bank Facilities, Fund-based - LT-Cash Credit (770.00), Fund-based - LT-Term Loan (117.05), Fund-based - LT-Working Capital Demand loan (100.00), and Non-fund-based - ST-BG/LC (75.00), received positive and stable outlooks, and CareEdge Ratings indicated they will closely monitor net leverage.